A Study of Ivonescimab in People With Endometrial and Cervical Cancers
Status:
RECRUITING
Trial end date:
2027-04-04
Target enrollment:
Participant gender:
Summary
The researchers are doing this study to find out if ivonescimab is an effective treatment for people with endometrial cancer (EC) and/or cervical cancer (CC). The researchers will also look at whether the study drug is safe and causes few or mild side effects in participants.